Want to see JP:4109 full AI Analyst Report?
4109 Stock Chart & Stats
¥4150.00
¥10.00(0.22%)
At close: 4:00 PM EST
¥4150.00
¥10.00(0.22%)
Day’s Range― - ―
52-Week Range¥3,890.00 - ¥8,100.00
Previous CloseN/A
Volume63.10K
Average Volume (3M)23.73K
Market Cap
¥70.03B
Enterprise Value¥48.48K
Total Cash (Recent Filing)¥14.82B
Total Debt (Recent Filing)¥5.75B
Price to Earnings (P/E)22.0
Beta0.82
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.94%
Share Statistics
EPS (TTM)258.39
Shares Outstanding12,973,248
10 Day Avg. Volume21,250
30 Day Avg. Volume23,733
Financial Highlights & Ratios
PEG Ratio2.57
Price to Book (P/B)1.19
Price to Sales (P/S)1.55
P/FCF Ratio39.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)256.9
Revenue Forecast (FY)¥39.78B
Bulls Say, Bears Say
Bulls Say
Low Leverage And Growing Equity BaseA very low debt-to-equity ratio and steadily rising equity provide durable financial resilience versus industry cycles. This balance-sheet strength supports capital spending, weathering downturns, and preserves strategic optionality for M&A or product investments without stressing interest coverage.
Specialty High-Purity Product FocusConcentration on high-purity specialty chemicals and purification expertise creates structural competitive advantage. These products serve electronics and industrial supply chains where quality and technical barriers limit suppliers, supporting more stable pricing and deeper customer relationships over time.
Recovered Margins And Return To GrowthMeaningful margin recovery alongside renewed revenue growth indicates operational leverage and better pricing/mix or cost discipline. Sustained margin improvement increases cash flow potential and competitiveness, helping the business rebuild returns toward prior peak levels if end-market conditions hold.
Bears Say
Volatile Free Cash FlowLarge swings in free cash flow suggest working-capital sensitivity and uneven capex timing, reducing predictability of internal funding for dividends, buybacks, or reinvestment. This volatility increases financing and planning risk across multi-quarter cycles for capital-intensive specialty chemical operations.
Cyclical Profitability Below 2022 PeakProfitability is cyclical and still short of prior highs, indicating exposure to end-market swings or pricing cycles. Persistent gap to historical peak margins implies the company may face structural pricing pressure or product-mix limits that constrain sustained return improvements.
Subdued Shareholder Returns (ROE)Lower return on equity versus past peak signals inefficiency in translating assets and equity into profits. If ROE stays depressed, capital allocation attractiveness falls and the company may struggle to meet investor expectations absent structural margin or growth recovery.
Stella Chemifa News
4109 FAQ
What was Stella Chemifa Corporation’s price range in the past 12 months?
Stella Chemifa Corporation lowest stock price was ¥3890.00 and its highest was ¥8100.00 in the past 12 months.
What is Stella Chemifa Corporation’s market cap?
Stella Chemifa Corporation’s market cap is ¥70.03B.
When is Stella Chemifa Corporation’s upcoming earnings report date?
Stella Chemifa Corporation’s upcoming earnings report date is Aug 06, 2026 which is in 13 days.
How were Stella Chemifa Corporation’s earnings last quarter?
Stella Chemifa Corporation released its earnings results on May 14, 2026. The company reported ¥54.35 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Stella Chemifa Corporation overvalued?
According to Wall Street analysts Stella Chemifa Corporation’s price is currently Overvalued.
Does Stella Chemifa Corporation pay dividends?
Stella Chemifa Corporation pays a Semiannually dividend of ¥90 which represents an annual dividend yield of 2.94%. See more information on Stella Chemifa Corporation dividends here
What is Stella Chemifa Corporation’s EPS estimate?
Stella Chemifa Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stella Chemifa Corporation have?
Stella Chemifa Corporation has 12,973,248 shares outstanding.
What happened to Stella Chemifa Corporation’s price movement after its last earnings report?
Stella Chemifa Corporation reported an EPS of ¥54.35 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.805%.
Which hedge fund is a major shareholder of Stella Chemifa Corporation?
Currently, no hedge funds are holding shares in JP:4109
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Stella Chemifa Corporation
Stella Chemifa Corporation, a Japanese company established in 1916 and headquartered in Osaka, specializes as a global manufacturer and supplier of inorganic fluorine compounds. Formerly known as Hashimoto Chemical Corporation until its rebranding in 1997, the company offers a comprehensive product portfolio tailored for diverse industrial applications worldwide. For the electronics sector, Stella Chemifa provides essential materials such as hydrofluoric acid, buffered hydrofluoric acid, and various etching solutions used in the production of semiconductors, liquid crystal displays, and solar cells. It also supplies a range of metal fluorides, including calcium, aluminum, and lithium fluoride, crucial for optical applications, alongside lithium hexafluorophosphate for battery manufacturing. Its offerings extend to numerous boron trifluoride compounds, serving as vital reactive catalysts across different chemical processes. Additionally, the company produces anhydrous hydrofluoric acid and 55% hydrofluoric acid, utilized in surface treatment and as more environmentally conscious alternatives to CFCs. Stella Chemifa also supports the nuclear energy industry with potassium fluoroborate and boric acid, and provides tin fluoride (II) USP for products requiring GMP compliance. Beyond these specialized compounds, the company's extensive catalog includes a broad array of other fluorochemicals, such as fluorosilicic acid, various fluorosilicates, fluoroboric acid, diverse fluoroborates, and a selection of ammonium, sodium, and potassium fluorides. Complementing its manufacturing operations, Stella Chemifa offers logistics services for the transportation of specialized chemical substances, high-pressure gases, and hazardous materials. Demonstrating a commitment to innovation, the company is also actively involved in the development of Boron Neutron Capture therapy for cancer treatment.
Technical Analysis
Osaka Organic Chemical Industry Ltd.
―
Sumitomo Seika Chemicals Co., Ltd.
―
Sakai Chemical Industry Co., Ltd.
―
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
―
Nippon Fine Chemical Co., Ltd.
―





